High materiality7/10
H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy on Opus Genetics with a target of $8; current price is $3.90.
- Target 8; Posted price 3.90; Firm H.C. Wainwright; Analyst Matthew Caufield
Key facts
- 01
Target: $8
- 02
Posted price: $3.9
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Matthew Caufield
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.